The Indian rupee is likely to open weaker on Wednesday after upbeat U.S. economic data lifted U.S. bond yields, prompting the dollar to resume its uptrend. The one-month non-deliverable forward indicated that the rupee will open at 85.80-85.81 to the U.S. dollar, compared with 85.7125 in the previous session. The dollar index dipped during Asia trade to 108.5 after rising 0.3% on Tuesday.

Mahindra and Mahindra (M&M) shares will remain in focus on Wednesday, January 8, following the automaker's announcement of prices for the highly anticipated Mahindra XEV 9e and BE 6 top-end models. Both electric SUVs will be offered in three variants, including Pack One, Pack Two, and Pack Three. The company had earlier announced the price of the basic models.

Geojit Financial Services's report on Daily Agri Picks: India's exports of spices rose 10% on year to 940,997.50 tonnes in Apr-Oct, according to data from the Spices Board of India. The country exported 146,557.83 tonnes of jeera during the period, up 73% on year, the data showed. In dollar terms, the total exports of spices were up 7% on year at $2.54 billion during Apr-Oct.

Complete Circle Capital's wealth management arm has raised $3 million in its maiden fund raise from investors led by Rajeev and Arjun Juneja from Mankind Pharma Promoter Family Office, along with Narinder Bajaj, the Director and Chairman of Mitutoyo South Asia Pvt. Ltd. It also plans to roll out AI-based technology to help investors and clients.

In Budget 2024, Finance Minister Nirmala Sitharaman introduced changes to the income tax slabs to make the new tax regime more appealing to taxpayers. However, no such perks were announced in the July 2024 Budget for those who opted for the old tax regime. The standard deduction for salaried individuals has been increased to ₹75,000 in the new regime.

Mumbai-based dental products company Laxmi Dental will open its Rs 698-crore initial share sale for public subscription on January 13, with a price band of Rs 407-428 per share. The issue will close on January 15. The anchor book of the public issue will be launched for a day on January 10, a day prior to the offer opening for public. The IPO share allotment will be finalised by 16.

India’s new central bank head faces a tough decision on managing rupee’s exchange rate- focus on squeezing volatility like his predecessor did, or respond to calls for more flexibility as dollar continues to surge. A gauge of the rupee’s inflation-adjusted trade competitiveness, or real effective exchange rate, rose to a historic high of 108.14 in November, suggesting an overvaluation of about 8%.

Kotak Institutional Equities has initiated coverage on 📌Premier Energies and 📌Waaree Energies with a "sell" call, citing high valuations, despite forecasting strong growth in India's solar sector. The brokerage set target prices of Rs 770 for Premier Energies and Rs 2,550 for Waaree Energies, indicating potential declines.

U.S. stocks fell on Tuesday following positive economic data that raised concerns about inflation slowing down the Federal Reserve's monetary policy easing. This decline was driven by unexpected job openings and increased services sector activity. Bond yields rose, affecting technology stocks. Investors are concerned about the impact of possible future tariffs.

India's market regulator, SEBI, has uncovered a plot to generate millions of dollars in illegal gains through the trades of Capital Group, a Los Angeles-based fund manager with $2.6 trillion in equity stakes. Ketan Parekh, a former stockbroker, allegedly orchestrated the scheme, using nonpublic information to enrich himself and others.

GMR Power and Urban Infra Ltd on Wednesday, January 8, said it has secured approval from the Indian Renewable Energy Development Agency Limited (‘IREDA’) to part finance the project to install and maintain 75.69 lakh smart meters across various zones in Uttar Pradesh. Shares of GMR Power and Urban Infra were trading 1.24% lower at ₹127.10 on the BSE around 10:10 am.

Shares of Dr. Reddy's Laboratories jumped as much as 4% on Wednesday to Rs 1,404.60 on the BSE after brokerage firm Nuvama Institutional Equities upgraded its rating on the stock to 'buy,' expressing confidence in the drugmaker's proactive measures to offset the anticipated financial impact from the patent expiry of its blockbuster cancer drug Revlimid in 2026.

Samsrita Labs Q3 Results 2025:Samsrita Labs declared their Q3 results on 06 Jan, 2025. The topline decreased by 0% and the loss decreased by 10.99% year-over-year. The company reported a loss of ₹0.04 crore and revenue at ₹0 crore. As compared to the previous quarter, the revenue also declined by 0%, while the loss showed a decrease of 9.6%.

U H Zaveri Q3 Results 2025: U H Zaveri declared their Q3 results on 07 Jan, 2025, revealing a significant increase in topline by 100.85% year-over-year. However, the profit faced a drastic decline of 94.82% YoY, amounting to ₹0.02 crore. The revenue for the quarter stood at ₹15.51 crore. In comparison to the previous quarter, U H Zaveri experienced revenue growth of 130.98%.

Emerald Finance Q3 Results 2025:Emerald Finance declared their Q3 results on 06 Jan, 2025. The topline increased by 67.53% & the profit increased by 105.38% YoY. Profit at ₹2.48 crore and revenue at ₹5.72 crore. As compared to the previous quarter, the revenue grew by 14.42% and the profit increased by 20.53%. However, the Selling, general & administrative expenses rose by 0.04% q-o-q.